CVS to sell CBD-infused topical products in 800 stores across 8 states
Category: #retail  By Paroma Bhattacharya  Date: 2019-03-23
  • share
  • Twitter
  • Facebook
  • LinkedIn

CVS to sell CBD-infused topical products in 800 stores across 8 states

CVS has partnered with cannabis producers to infuse CBD and sell topical products like roll-ons, lotions, creams, slaves and sprays.

CVS pharmacy has announced that it would sell hemp-derived CBD products, or products with cannabidiol, which is non-psychoactive component of marijuana, in about 800 stores in states including Colorado, Illinois, Indiana, California, Maryland, Indiana, Kentucky and Tennessee. CVS has partnered with cannabis producers to infuse CBD and sell topical products like roll-ons, lotions, creams, slaves and sprays.

As per reported by WFLA TV, CVS stated that it is not selling CBD containing food additives or supplements as it is illegal to add drugs like CBD in food supply. CBD is derived from cannabis plant and is non-psychoactive. So far, there is no approval of Food and Drug Administration to use CBD in food or beverage products.

CVS Health CEO, Larry Merlo reportedly quoted stating that they have feedbacks from their customers that these products are relieving them from pain for arthritis and other ailments. He further added that they will keep their pace slow, but they think that customer will demand more for these products as a part of health offerings.

Cannabis species hemp has no psychoactive compounds that can cause user to get high, like marijuana. Hemp is not a controlled substance now so there are more business opportunities in creating hemp-based products like tinctures and lotions. There are a lot many ways to use CBD but studies on CBD are limited yet.

Reportedly, CVS stated that they are not claiming a ‘cure-all’ product as effectiveness may vary from product to product.

According to experts, CBD has been used for treatment of inflammation, pain, anxiety and cancer. Epidiolex is the only FDA approved CBD oil which is prescribed to treat seizures related with two rare, severe forms of epilepsy.

CVS has collaborated with Eurofins, which is a third-party laboratory, to ensure labeling and safety of customers. They will test all CBD topicals for CBD, THC content and other contaminants.



About Author

Paroma Bhattacharya

Email: [email protected]   

Paroma Bhattacharya

Paroma currently works as a content developer for Algosonline, MSF and a series of alike platforms. Fortified with a post-graduation degree in Journalism and Mass Communication, she delved head long into a writing career, creating resourceful and information enriched ...

Read More

More News By Paroma Bhattacharya

MacroGenics, I-Mab team up to develop & market enoblituzumab in China
MacroGenics, I-Mab team up to develop & market enoblituzumab in China
By Paroma Bhattacharya

MacroGenics, Inc. and I-Mab Biopharma, a U.S. and China based clinical-stage biopharmaceutical company that is committed to discover and develop biologics in autoimmune and immune-oncology diseases, have recently announc...

ViiV Healthcare announces positive result in TANGO Phase 3 study
ViiV Healthcare announces positive result in TANGO Phase 3 study
By Paroma Bhattacharya

ViiV Healthcare Limited, a pharmaceutical company specializing in HIV treatment, recently announced positive results from Phase 3 TANGO study.

The study was conducted to assess vira...

Skyhawk Therapeutics expands licensing partnership with Biogen
Skyhawk Therapeutics expands licensing partnership with Biogen
By Paroma Bhattacharya

Skyhawk Therapeutics, Inc. has recently announced the expansion of its partnership with Biogen, which was initially announced on January 4, 2019.

The expansion, which leverages on the breadth of SkySTAR™ technology platform from Skyh...